Abstract Details

Title Salvage Chemotherapy with Bevacizumab for Recurrent Alkylator-Refractory Anaplastic Astrocytoma

Topic Neurometabolic Disorders/Neurotoxicology/Neuroendocrinology

Presentation(s) (-)

Poster/Presentation
Number 005

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Marc Chamberlain, MD (Cascadian Therapeutics)	No disclosure on file
	No disclosure on file
Saud Sadiq, BS, FAAN (Tisch Multiple Sclerosis Research Center of New York)	Ms. Brewi has nothing to disclose.
	No disclosure on file

��ɫ����